S. Brassell

发表

Clinical potential of the ERG oncoprotein in prostate cancer

Isabell A. Sesterhenn, David G. McLeod, S. Srivastava, 2012, Nature Reviews Urology.

Update on magnetic resonance imaging, ProstaScint, and novel imaging in prostate cancer*

D. Mcleod, S. Brassell, I. Rosner, 2005, Current opinion in urology.

Assessment of circulating tumor cells (CTCs) in prostate cancer patients with low‐volume tumors

J. Moul, S. Srivastava, I. Sesterhenn, 2010, Pathology international.

Fusion Imaging: A Novel Staging Modality in Testis Cancer

N. Schenkman, S. Brassell, M. Javitt, 2010, Journal of Cancer.

Correlation of endorectal coil magnetic resonance imaging of the prostate with pathologic stage

John A. Taylor, S. Brassell, W. Krueger, 2004, World Journal of Urology.

7. RIU0472_07-31.qxd

D. Mcleod, S. Brassell, K. Rice, 2010 .

Long‐term overall survival and metastasis‐free survival for men with prostate‐specific antigen‐recurrent prostate cancer after prostatectomy: analysis of the Center for Prostate Disease Research National Database

E. Antonarakis, M. Eisenberger, Yongmei Chen, 2011, BJU international.

Elevated alkaline phosphatase velocity strongly predicts overall survival and the risk of bone metastases in castrate-resistant prostate cancer.

T. Brand, A. Metwalli, Yongmei Chen, 2014, Urologic oncology.

Induction of a cellular immune response to a foreign antigen by a recombinant Listeria monocytogenes vaccine.

D. Portnoy, R. Schafer, S. Brassell, 1992, Journal of immunology.

The self antigen heme evades immune recognition by sequestration in some hemoproteins

R. Sutherland, S. Brassell, Y. Paterson, 1995, European journal of immunology.

Advances made in the treatment of testicular cancer in the U.S. Military: 1946 to the present.

D. Mcleod, S. Brassell, D. Hawksworth, 2009, Urologic oncology.

Contemporary intravesical treatment options for urothelial carcinoma of the bladder.

A. Kamat, S. Brassell, 2006, Journal of the National Comprehensive Cancer Network : JNCCN.

Increased frequency of germline BRCA2 mutations associates with prostate cancer metastasis in a racially diverse patient population

S. Ambs, S. Srivastava, I. Sesterhenn, 2018, Prostate Cancer and Prostatic Diseases.

PCA3 score before radical prostatectomy predicts extracapsular extension and tumor volume.

S. Srivastava, I. Sesterhenn, Yongmei Chen, 2008, The Journal of urology.

The Center for Prostate Disease Research (CPDR): a multidisciplinary approach to translational research.

S. Srivastava, G. Petrovics, A. Dobi, 2009, Urologic oncology.

Low risk prostate cancer in men ≥ 70 years old: to treat or not to treat.

Yongmei Chen, D. Mcleod, M. Colombo, 2013, Urologic oncology.

Perioperative complications of radical retropubic prostatectomy.

D. Mcleod, S. Brassell, J. Sterbis, 2005, Clinical genitourinary cancer.

Clinicopathological behavior of single focus prostate adenocarcinoma.

I. Sesterhenn, Yongmei Chen, D. Mcleod, 2009, The Journal of urology.

Racial/Ethnic Patterns in Prostate Cancer Outcomes in an Active Surveillance Cohort

T. Brand, Yongmei Chen, D. Mcleod, 2011, Prostate cancer.

Prostate cancer in men 70 years old or older, indolent or aggressive: clinicopathological analysis and outcomes.

Yongmei Chen, D. Mcleod, J. Cullen, 2011, The Journal of urology.

The burden of prostate cancer in Asian nations

Yongmei Chen, D. Mcleod, M. Colombo, 2012, Journal of carcinogenesis.

Prostate cancer in men less than the age of 50: a comparison of race and outcomes.

Yongmei Chen, D. Mcleod, J. Cullen, 2011, Urology.

Merkel cell carcinoma as a solitary metastasis to the testis.

S. Brassell, I. Rosner, E. Whitman, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Venous thromboembolism in urologic surgery: prophylaxis, diagnosis, and treatment.

D. Mcleod, S. Brassell, K. Rice, 2010, Reviews in urology.

Prostate cancer in men under the age of 50: A comparison of race and outcomes.

Yongmei Chen, D. Mcleod, S. Brassell, 2010 .

Prostate-specific antigen versus prostate-specific antigen density as predictor of tumor volume, margin status, pathologic stage, and biochemical recurrence of prostate cancer.

J. Moul, T. Kao, S. Brassell, 2005, Urology.

The design and implementation of a multidisciplinary prostate cancer clinic.

R. P. Hudak, D. Mcleod, S. Brassell, 2007, Urologic nursing.

D. Mcleod, J. Cullen, S. Brassell, 2013, Urologic oncology.

Evaluation of the ETS-Related Gene mRNA in Urine for the Detection of Prostate Cancer

S. Srivastava, I. Sesterhenn, S. Miick, 2010, Clinical Cancer Research.

Comprehensive quality-of-life outcomes in the setting of a multidisciplinary, equal access prostate cancer clinic.

L. Black, J. Cullen, S. Brassell, 2010, Urology.

152 ALL-CAUSE MORTALITY AMONG MILITARY HEALTH CARE BENEFICIARIES WITH PROSTATE CANCER UNDERGOING ACTIVE SURVEILLANCE

S. Srivastava, Yongmei Chen, D. Mcleod, 2011 .